Response Genetics' Q1 Revenues Increase 40 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics company Response Genetics today reported a 40 percent increase year over year in its first-quarter revenues.

The Los Angeles-based company said that for the three months ended March 31, revenues rose to $5.6 million from $4.0 million. Revenues from its pharmaceutical clients increased 137 percent year over year, while revenues generated by ResponseDX products rose 8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.